Sex differences in the efficacy, safety and persistence of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of phase III and long-term extension trials

Authors

Institutions

Publication Details

Journal
BMJ Open
Published
2025-12-01
DOI
https://doi.org/10.1136/bmjopen-2023-082366
Citations
1
Primary Topic
Rheumatoid Arthritis Research and Therapies
Type
article
Field-Weighted Citation Impact
1.67
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sex differences in the efficacy, safety and persistence of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of phase III and long-term extension trials

Eduardo Mysler, Samar A. Al-Emadi, C. A. Connell, V. Strand et al.
1 citations
BMJ Open
Rheumatoid Arthritis Research and Therapies
1.67
article

Sex differences in the efficacy, safety and persistence of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of phase III and long-term extension trials

Eduardo Mysler, Samar A. Al-Emadi, C. A. Connell, V. Strand, David Gruben, C. Kinch, Hendrik Schulze-Koops, Rebecca Germino
article en
1 citations

Abstract

No abstract available for this paper.
BMJ OpenVol. 15(12)
Pfizer (United States) (US), Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno (AR), Pfizer (Canada) (CA), Hamad Medical Corporation (QA), Ludwig-Maximilians-Universität München (DE), Stanford University (US)
Openalex Percentile: Top 11%
Rheumatoid Arthritis Research and Therapies
1.67
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.